PortViewPortView
Equillium logo

Equillium (EQ) Stock Analysis

NASDAQHealthcareBiotechnology

$2.21+0.23%
1-year price historyRange $0.84 – $3.20
52-week range$2.21
$0.76$3.54

What Equillium does

Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical development that targets the novel CD6 immune checkpoint receptor. Itolizumab is currently in Phase III trials for acute graft-versus-host disease, has completed Phase Ib studies for asthma, and is also undergoing Phase Ib trials for lupus nephritis. In addition to itolizumab, Equillium is advancing EQ101 for the treatment of cutaneous T cell lymphoma and alopecia areata, and EQ102, which targets various gastrointestinal conditions. Headquartered in La Jolla, California, the company was incorporated in 2017 and previously operated as Attenuate Biopharmaceuticals, Inc. before changing its name to Equillium, Inc. in May 2017.

Key metrics

Market cap
$139.73M
P/E (TTM)
-6.91
EPS (TTM)
$-0.32
Beta
1.81
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$2.52
200-day avg
$1.97
52-week high
$3.54
52-week low
$0.76
CEO
Bruce D. Steel

ETFs linked to EQ

Broad-market and Healthcare sector ETFs an investor holding Equillium is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how EQ fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze EQ in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Equillium?
Equillium trades under the ticker EQ on NASDAQ.
Which exchange is EQ listed on?
EQ is listed on NASDAQ.
What sector does Equillium operate in?
Equillium is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze EQ in a portfolio?
PortView shows EQ's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.